Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin

Pharmacogenomics. 2012 Aug;13(11):1215-8. doi: 10.2217/pgs.12.85.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Biomarkers, Pharmacological
  • Blood Coagulation / drug effects
  • Clopidogrel
  • Cytochrome P-450 CYP2C9
  • Humans
  • Mixed Function Oxygenases / genetics*
  • Pharmacogenetics
  • Point-of-Care Systems*
  • Ticlopidine / administration & dosage
  • Ticlopidine / analogs & derivatives*
  • Vitamin K Epoxide Reductases
  • Warfarin / administration & dosage*

Substances

  • Biomarkers, Pharmacological
  • Warfarin
  • Clopidogrel
  • Mixed Function Oxygenases
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9
  • Aryl Hydrocarbon Hydroxylases
  • Vitamin K Epoxide Reductases
  • Ticlopidine